Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pasithea Therapeutics (KTTA) Cash from Investing Activities (2021 - 2023)

Historic Cash from Investing Activities for Pasithea Therapeutics (KTTA) over the last 3 years, with Q4 2023 value amounting to $54536.0.

  • Pasithea Therapeutics' Cash from Investing Activities rose 10232.87% to $54536.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $75199.0, marking a year-over-year increase of 10326.99%. This contributed to the annual value of $75199.0 for FY2023, which is 10326.99% up from last year.
  • Latest data reveals that Pasithea Therapeutics reported Cash from Investing Activities of $54536.0 as of Q4 2023, which was up 10232.87% from $50159.0 recorded in Q3 2023.
  • Pasithea Therapeutics' Cash from Investing Activities' 5-year high stood at $70121.0 during Q2 2022, with a 5-year trough of -$2.3 million in Q4 2022.
  • Its 3-year average for Cash from Investing Activities is -$248603.7, with a median of -$1951.0 in 2022.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first crashed by 1800795.64% in 2022, then skyrocketed by 29316.44% in 2023.
  • Pasithea Therapeutics' Cash from Investing Activities (Quarter) stood at -$12933.0 in 2021, then crashed by 18007.96% to -$2.3 million in 2022, then surged by 102.33% to $54536.0 in 2023.
  • Its Cash from Investing Activities stands at $54536.0 for Q4 2023, versus $50159.0 for Q3 2023 and $24392.0 for Q2 2023.